ELCC 2019

Current Management of Early Stage NSCLC

Trial Data: Early Stage Lung Cancer

Immunotherapy in Stage 4 Lung Cancer

I-O monotherapy

Presented By

Prof. Martin Reck, Airway Research Center North, Grosshansdorf, Germany

Trial

CheckMate 026, Keynote-024, Checkmate 227, MYSTIC, B-F1RST

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 23:13

Combo I-O plus chemotherapy

Presented By

Dr Luis Paz-Ares, Complutense University of Madrid, Spain

Trial

Keynote-189, Impower-132

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 22:15

Other I-O combinations

Presented By

Prof. Solange Peters, Lausanne University Hospital and Ludwig Institute, Switzerland

Trial

IMpower 150

Conference

ELCC 2019

25 June 2019 21:17

Predictive diagnostics for I-O

Presented By

Dr Enriqueta Felip, Vall d’Hebron University Hospital, Spain

Trial

Phase 3, BFAST

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 13:19

Trials: Immunotherapy in Stage 4 Lung Cancer

Post-discontinuation immunotherapy in PACIFIC

Presented By

Dr Phillip Dennis, Dr Marina Garassino

Trial

Phase 3, PACIFIC

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 23:23

Post-study immunotherapy in MYSTIC

Presented By

Dr Niels Reinmuth, Asklepios Lung Clinic, Munich-Gauting, Germany

Trial

Phase 3, MYSTIC

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 13:26

Implementation of Personalised Lung Cancer Care in Clinical Routine

Experiences from Germany

Presented By

Prof. Jürgen Wolf, University Hospital of Cologne, Germany

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 23:31

Experiences from France

Presented By

Dr Benjamin Besse, Institut Gustave Roussy, France

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 20:57

How can societies help to implement personalised treatment?

Presented By

Prof. Rolf Stahel, Prof. Giorgio Scagliotti

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 07:59

Optimal Management of Brain Metastases in NSCLC

Small Cell Lung Cancer: New Targets

Molecular characteristics of SCLC

Presented By

Dr Simon Ekman, Karolinska University Hospital, Sweden

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 23:13

Immunotherapy in SCLC: trial data

Presented By

Dr Enriqueta Felip, Vall d’Hebron University Hospital, Spain

Trial

CA184-156, CheckMate-451, CASPIAN, Keynote-604, Checkmate 032

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 08:15